Trial Profile
A Phase II, randomized, assessor-blind, placebo-controlled, multicenter, comparative, prospective study to assess the efficacy and safety of Viracure cream in immunocompetent patients with Genital Herpes due to Herpes Simplex Virus -2 infection.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Aug 2016
Price :
$35
*
At a glance
- Drugs PP 9706642 (Primary)
- Indications Herpes genitalis; Herpes simplex virus type 2 infections
- Focus Therapeutic Use
- Sponsors Piramal Phytocare
- 03 Oct 2011 New trial record